Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course

To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion-based recommendations for promoting exercise and lifestyle physical activity across disability levels. The National MS Society ("Society") convened clinical and research experts in the fi...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Multiple sclerosis Ročník 26; číslo 12; s. 1459
Hlavní autori: Kalb, Rosalind, Brown, Theodore R, Coote, Susan, Costello, Kathleen, Dalgas, Ulrik, Garmon, Eric, Giesser, Barbara, Halper, June, Karpatkin, Herb, Keller, Jennifer, Ng, Alexander V, Pilutti, Lara A, Rohrig, Amanda, Van Asch, Paul, Zackowski, Kathleen, Motl, Robert W
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 01.10.2020
Predmet:
ISSN:1477-0970, 1477-0970
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion-based recommendations for promoting exercise and lifestyle physical activity across disability levels. The National MS Society ("Society") convened clinical and research experts in the fields of MS, exercise, rehabilitation, and physical activity to (1) reach consensus on optimal exercise and lifestyle physical activity recommendations for individuals with MS at disability levels 0-9.0 on the Expanded Disability Status Scale (EDSS) and (2) identify and address barriers/facilitators for participation. Based on current evidence and expert opinion, the Society makes the following recommendations, endorsed by the Consortium of Multiple Sclerosis Centers:Healthcare providers should endorse and promote the benefits/safety of exercise and lifestyle physical activity for every person with MS.Early evaluation by a physical or occupational therapist or exercise or sport scientist, experienced in MS (hereafter referred to as "specialists"), is recommended to establish an individualized exercise and/or lifestyle physical activity plan.Taking into account comorbidities and symptom fluctuations, healthcare providers should encourage ⩾150 min/week of exercise and/or ⩾150 min/week of lifestyle physical activity.Progress toward these targets should be gradual, based on the person's abilities, preferences, and safety.If disability increases and exercise/physical activity becomes more challenging, referrals to specialists are essential to ensure safe and appropriate prescriptions.When physical mobility is very limited, exercise should be facilitated by a trained assistant.
AbstractList To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion-based recommendations for promoting exercise and lifestyle physical activity across disability levels. The National MS Society ("Society") convened clinical and research experts in the fields of MS, exercise, rehabilitation, and physical activity to (1) reach consensus on optimal exercise and lifestyle physical activity recommendations for individuals with MS at disability levels 0-9.0 on the Expanded Disability Status Scale (EDSS) and (2) identify and address barriers/facilitators for participation. Based on current evidence and expert opinion, the Society makes the following recommendations, endorsed by the Consortium of Multiple Sclerosis Centers:Healthcare providers should endorse and promote the benefits/safety of exercise and lifestyle physical activity for every person with MS.Early evaluation by a physical or occupational therapist or exercise or sport scientist, experienced in MS (hereafter referred to as "specialists"), is recommended to establish an individualized exercise and/or lifestyle physical activity plan.Taking into account comorbidities and symptom fluctuations, healthcare providers should encourage ⩾150 min/week of exercise and/or ⩾150 min/week of lifestyle physical activity.Progress toward these targets should be gradual, based on the person's abilities, preferences, and safety.If disability increases and exercise/physical activity becomes more challenging, referrals to specialists are essential to ensure safe and appropriate prescriptions.When physical mobility is very limited, exercise should be facilitated by a trained assistant.
To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion-based recommendations for promoting exercise and lifestyle physical activity across disability levels.OBJECTIVESTo provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion-based recommendations for promoting exercise and lifestyle physical activity across disability levels.The National MS Society ("Society") convened clinical and research experts in the fields of MS, exercise, rehabilitation, and physical activity to (1) reach consensus on optimal exercise and lifestyle physical activity recommendations for individuals with MS at disability levels 0-9.0 on the Expanded Disability Status Scale (EDSS) and (2) identify and address barriers/facilitators for participation.METHODSThe National MS Society ("Society") convened clinical and research experts in the fields of MS, exercise, rehabilitation, and physical activity to (1) reach consensus on optimal exercise and lifestyle physical activity recommendations for individuals with MS at disability levels 0-9.0 on the Expanded Disability Status Scale (EDSS) and (2) identify and address barriers/facilitators for participation.Based on current evidence and expert opinion, the Society makes the following recommendations, endorsed by the Consortium of Multiple Sclerosis Centers:Healthcare providers should endorse and promote the benefits/safety of exercise and lifestyle physical activity for every person with MS.Early evaluation by a physical or occupational therapist or exercise or sport scientist, experienced in MS (hereafter referred to as "specialists"), is recommended to establish an individualized exercise and/or lifestyle physical activity plan.Taking into account comorbidities and symptom fluctuations, healthcare providers should encourage ⩾150 min/week of exercise and/or ⩾150 min/week of lifestyle physical activity.Progress toward these targets should be gradual, based on the person's abilities, preferences, and safety.If disability increases and exercise/physical activity becomes more challenging, referrals to specialists are essential to ensure safe and appropriate prescriptions.When physical mobility is very limited, exercise should be facilitated by a trained assistant.RECOMMENDATIONSBased on current evidence and expert opinion, the Society makes the following recommendations, endorsed by the Consortium of Multiple Sclerosis Centers:Healthcare providers should endorse and promote the benefits/safety of exercise and lifestyle physical activity for every person with MS.Early evaluation by a physical or occupational therapist or exercise or sport scientist, experienced in MS (hereafter referred to as "specialists"), is recommended to establish an individualized exercise and/or lifestyle physical activity plan.Taking into account comorbidities and symptom fluctuations, healthcare providers should encourage ⩾150 min/week of exercise and/or ⩾150 min/week of lifestyle physical activity.Progress toward these targets should be gradual, based on the person's abilities, preferences, and safety.If disability increases and exercise/physical activity becomes more challenging, referrals to specialists are essential to ensure safe and appropriate prescriptions.When physical mobility is very limited, exercise should be facilitated by a trained assistant.
Author Keller, Jennifer
Van Asch, Paul
Zackowski, Kathleen
Garmon, Eric
Halper, June
Ng, Alexander V
Karpatkin, Herb
Motl, Robert W
Pilutti, Lara A
Brown, Theodore R
Rohrig, Amanda
Dalgas, Ulrik
Giesser, Barbara
Kalb, Rosalind
Coote, Susan
Costello, Kathleen
Author_xml – sequence: 1
  givenname: Rosalind
  surname: Kalb
  fullname: Kalb, Rosalind
  organization: National Multiple Sclerosis Society, New York, NY, USA
– sequence: 2
  givenname: Theodore R
  surname: Brown
  fullname: Brown, Theodore R
  organization: EvergreenHealth, Kirkland, WA, USA
– sequence: 3
  givenname: Susan
  surname: Coote
  fullname: Coote, Susan
  organization: School of Allied Health and Health Research Institute, University of Limerick, Limerick, Ireland
– sequence: 4
  givenname: Kathleen
  surname: Costello
  fullname: Costello, Kathleen
  organization: National Multiple Sclerosis Society, New York, NY, USA
– sequence: 5
  givenname: Ulrik
  orcidid: 0000-0003-4132-2789
  surname: Dalgas
  fullname: Dalgas, Ulrik
  organization: Section of Sport Science, Department of Public Health, Aarhus University, Aarhus, Denmark
– sequence: 6
  givenname: Eric
  surname: Garmon
  fullname: Garmon, Eric
  organization: National Multiple Sclerosis Society, New York, NY, USA
– sequence: 7
  givenname: Barbara
  surname: Giesser
  fullname: Giesser, Barbara
  organization: Pacific Neuroscience Institute, Santa Monica, CA, USA
– sequence: 8
  givenname: June
  surname: Halper
  fullname: Halper, June
  organization: Consortium of Multiple Sclerosis Centers and International Organization of MS Nurses, Hackensack, NJ, USA
– sequence: 9
  givenname: Herb
  surname: Karpatkin
  fullname: Karpatkin, Herb
  organization: Program in Physical Therapy, Hunter College, New York, NY, USA
– sequence: 10
  givenname: Jennifer
  surname: Keller
  fullname: Keller, Jennifer
  organization: Motion Analysis Lab, Kennedy Krieger Institute, Baltimore, MD, USA
– sequence: 11
  givenname: Alexander V
  surname: Ng
  fullname: Ng, Alexander V
  organization: Exercise Science Program, Department of Physical Therapy, Marquette University, Milwaukee, WI, USA
– sequence: 12
  givenname: Lara A
  surname: Pilutti
  fullname: Pilutti, Lara A
  organization: Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada
– sequence: 13
  givenname: Amanda
  surname: Rohrig
  fullname: Rohrig, Amanda
  organization: Horizon Rehabilitation Centers, Omaha, NE, USA
– sequence: 14
  givenname: Paul
  surname: Van Asch
  fullname: Van Asch, Paul
  organization: Fit Up Neurological and Sport Physiotherapy, Antwerp, Belgium
– sequence: 15
  givenname: Kathleen
  surname: Zackowski
  fullname: Zackowski, Kathleen
  organization: National Multiple Sclerosis Society, New York, NY, USA
– sequence: 16
  givenname: Robert W
  orcidid: 0000-0002-5894-2290
  surname: Motl
  fullname: Motl, Robert W
  organization: UAB/Lakeshore Research Collaborative, The University of Alabama at Birmingham, Birmingham, AL, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32323606$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1LxDAQxYOsuB969yQ5ellNp02yOcqyfsCCFz2XNJm6kbapSar2v7eigsxh3sCP93izJLPOd0jIecauskzK6yznUPANB6YyLkAdkUVWSLlmSrLZPz0nyxhfGWNS5vyEzHOYRjCxIOPuE4NxEanuLG1cjTGNDdL-MEZndEO1Se7dpZEGNL5tsbM6Od9FWvtAe_T9BH-4dKDt0CT3fUXTYPDRRZoOwQ8vBz-kSSK1U4yekowfQsRTclzrJuLZ716R59vd0_Z-vX-8e9je7NemEJDWoCVuJKtFJSrLM24ra1RRm8yiUrIQhm3qGrRRHEBvoECtbWUA8txUaHgNK3L549sH_zZM9crWRYNNozv0QywhVwVwBUJM6MUvOlQt2rIPrtVhLP_eBV-m83K8
CitedBy_id crossref_primary_10_1136_bmjopen_2022_062160
crossref_primary_10_1080_17483107_2021_2010819
crossref_primary_10_1155_2022_2357785
crossref_primary_10_1177_03080226251355810
crossref_primary_10_3389_fneur_2022_1016143
crossref_primary_10_1177_13524585241305496
crossref_primary_10_7224_1537_2073_2024_038
crossref_primary_10_3389_fneur_2025_1521112
crossref_primary_10_1007_s00415_021_10935_6
crossref_primary_10_7759_cureus_30779
crossref_primary_10_1016_j_apmr_2025_05_017
crossref_primary_10_1016_j_msard_2024_105532
crossref_primary_10_1080_17483107_2024_2332322
crossref_primary_10_1016_j_cct_2023_107088
crossref_primary_10_1016_j_apmr_2023_10_020
crossref_primary_10_1177_1352458520958353
crossref_primary_10_1080_09593985_2024_2392183
crossref_primary_10_1002_jcsm_13050
crossref_primary_10_1080_09638288_2023_2252329
crossref_primary_10_1177_20552173221097580
crossref_primary_10_1016_j_jbmt_2024_03_050
crossref_primary_10_32725_jnss_2024_002
crossref_primary_10_3390_jfmk8040154
crossref_primary_10_2217_epi_2021_0296
crossref_primary_10_1249_MSS_0000000000003747
crossref_primary_10_1080_09638288_2021_1953622
crossref_primary_10_1016_j_msard_2023_105129
crossref_primary_10_1016_j_msard_2024_105689
crossref_primary_10_1177_02692155241262884
crossref_primary_10_1080_09638288_2024_2435519
crossref_primary_10_1016_j_msard_2025_106258
crossref_primary_10_1002_pmrj_12971
crossref_primary_10_1080_09638288_2022_2084774
crossref_primary_10_2478_rir_2022_0021
crossref_primary_10_3389_fneur_2024_1422078
crossref_primary_10_1016_j_cct_2025_108035
crossref_primary_10_1155_2024_6055245
crossref_primary_10_1177_1352458520943078
crossref_primary_10_1371_journal_pone_0288319
crossref_primary_10_1016_j_msard_2022_103693
crossref_primary_10_1016_j_jphys_2025_04_002
crossref_primary_10_3390_nu17061021
crossref_primary_10_1016_j_msard_2024_105552
crossref_primary_10_3389_fresc_2023_1258737
crossref_primary_10_1016_j_msard_2025_106709
crossref_primary_10_7224_1537_2073_2024_043
crossref_primary_10_1016_j_explore_2023_07_011
crossref_primary_10_1007_s00415_023_12147_6
crossref_primary_10_1007_s00421_024_05584_2
crossref_primary_10_3390_healthcare9101289
crossref_primary_10_1186_s12883_023_03187_6
crossref_primary_10_1016_j_bbi_2024_12_017
crossref_primary_10_1016_j_nbd_2022_105817
crossref_primary_10_1016_j_msard_2023_104896
crossref_primary_10_1016_j_msard_2024_105467
crossref_primary_10_3390_nu13113774
crossref_primary_10_1080_2159676X_2023_2245403
crossref_primary_10_1016_j_msard_2022_103843
crossref_primary_10_1016_j_evalprogplan_2023_102243
crossref_primary_10_1177_15598276251334360
crossref_primary_10_1016_j_msard_2025_106390
crossref_primary_10_1016_j_apmr_2022_06_001
crossref_primary_10_1080_17582024_2024_2389037
crossref_primary_10_3389_fneur_2024_1428712
crossref_primary_10_1177_15459683221131789
crossref_primary_10_1016_j_apmr_2020_06_001
crossref_primary_10_1080_09638288_2021_1934738
crossref_primary_10_1016_j_msard_2024_105458
crossref_primary_10_1080_09602011_2022_2107021
crossref_primary_10_1080_09638288_2025_2552871
crossref_primary_10_7759_cureus_80335
crossref_primary_10_1016_j_msard_2021_103177
crossref_primary_10_1016_j_msard_2024_105695
crossref_primary_10_1177_20552173211038035
crossref_primary_10_1016_j_cct_2023_107320
crossref_primary_10_1016_j_apmr_2023_03_026
crossref_primary_10_3390_biomedicines12122925
crossref_primary_10_3389_fneur_2021_746832
crossref_primary_10_2196_66091
crossref_primary_10_1097_PXR_0000000000000190
crossref_primary_10_1007_s13760_024_02677_9
crossref_primary_10_3390_jcm11237003
crossref_primary_10_3390_nu14194119
crossref_primary_10_1177_10105395241256158
crossref_primary_10_3390_jcm9113592
crossref_primary_10_1097_NPT_0000000000000504
crossref_primary_10_1186_s13643_021_01751_0
crossref_primary_10_3389_fneur_2023_1217000
crossref_primary_10_7224_1537_2073_2023_058
crossref_primary_10_1016_j_msard_2022_103701
crossref_primary_10_1016_j_msard_2024_105808
crossref_primary_10_2196_50729
crossref_primary_10_1016_j_msard_2024_105809
crossref_primary_10_1016_j_cct_2022_107056
crossref_primary_10_1016_j_msard_2022_103941
crossref_primary_10_1249_JES_0000000000000291
crossref_primary_10_1007_s00415_023_11806_y
crossref_primary_10_3389_fendo_2025_1557797
crossref_primary_10_1097_JSM_0000000000001310
crossref_primary_10_1080_08964289_2021_1935437
crossref_primary_10_7224_1537_2073_2020_091
crossref_primary_10_3390_ijms241713379
crossref_primary_10_1136_bmjopen_2020_045378
crossref_primary_10_1016_j_apmr_2025_02_005
crossref_primary_10_1016_j_msard_2024_105598
crossref_primary_10_1016_j_msard_2025_106621
crossref_primary_10_1016_j_kine_2025_02_011
crossref_primary_10_3389_fresc_2024_1303094
crossref_primary_10_3390_jcm14186625
crossref_primary_10_1177_13524585211072702
crossref_primary_10_1519_JPT_0000000000000356
crossref_primary_10_1177_1352458520969099
crossref_primary_10_1371_journal_pone_0264557
crossref_primary_10_1080_09638288_2022_2082564
crossref_primary_10_1016_j_msard_2023_104698
crossref_primary_10_1371_journal_pone_0272114
crossref_primary_10_1016_j_apmr_2024_09_020
crossref_primary_10_1177_13524585231204446
crossref_primary_10_3390_healthcare11111560
crossref_primary_10_2196_52733
crossref_primary_10_1177_13524585251356967
crossref_primary_10_2196_72213
crossref_primary_10_1249_MSS_0000000000003474
crossref_primary_10_1111_ene_16071
crossref_primary_10_1155_2022_6227377
crossref_primary_10_1016_j_neurot_2025_e00601
crossref_primary_10_1155_2024_4882755
crossref_primary_10_1177_13524585241301613
crossref_primary_10_1177_13524585241229332
crossref_primary_10_1016_j_msard_2023_104589
crossref_primary_10_2196_58026
crossref_primary_10_3389_fnagi_2022_960328
crossref_primary_10_1016_j_msard_2024_105817
crossref_primary_10_1186_s12883_024_03634_y
crossref_primary_10_1249_JES_0000000000000262
crossref_primary_10_1016_j_apmr_2021_07_001
crossref_primary_10_7224_1537_2073_2023_061
crossref_primary_10_1136_bmjopen_2023_076333
crossref_primary_10_1186_s12984_024_01383_0
crossref_primary_10_3390_nu17162713
crossref_primary_10_1371_journal_pone_0299611
crossref_primary_10_1123_japa_2021_0292
crossref_primary_10_1016_j_msard_2022_103742
crossref_primary_10_3389_fspor_2023_1162278
crossref_primary_10_1016_j_msard_2021_103388
crossref_primary_10_1186_s12883_023_03436_8
crossref_primary_10_1212_CON_0000000000001140
crossref_primary_10_2196_41371
crossref_primary_10_1016_j_apmr_2024_01_009
crossref_primary_10_1016_j_jsams_2021_08_015
crossref_primary_10_1055_a_2514_9160
crossref_primary_10_3389_fneur_2024_1373401
crossref_primary_10_3390_s25061780
crossref_primary_10_1080_15402002_2022_2157417
crossref_primary_10_1097_NPT_0000000000000430
crossref_primary_10_55453_rjmm_2025_128_3_10
crossref_primary_10_1016_j_msard_2022_104394
crossref_primary_10_1080_09638288_2025_2461265
crossref_primary_10_3390_s21113617
crossref_primary_10_7224_1537_2073_2021_134
crossref_primary_10_1177_13524585231204456
crossref_primary_10_1177_13524585231204459
crossref_primary_10_7224_1537_2073_2023_085
crossref_primary_10_1093_ptj_pzae037
crossref_primary_10_3390_ijerph191811839
crossref_primary_10_1016_j_scispo_2021_12_014
crossref_primary_10_1080_09638288_2023_2269845
crossref_primary_10_1016_j_msard_2024_106243
crossref_primary_10_1080_09593985_2025_2518261
crossref_primary_10_1016_j_actpsy_2025_105547
crossref_primary_10_1007_s00415_024_12395_0
crossref_primary_10_1097_PHM_0000000000002312
crossref_primary_10_1016_j_msard_2024_105865
crossref_primary_10_1016_j_msard_2025_106677
crossref_primary_10_1016_j_ypmed_2023_107754
crossref_primary_10_1016_j_ncl_2023_07_003
crossref_primary_10_1080_09638288_2022_2055159
crossref_primary_10_1007_s00415_025_13311_w
crossref_primary_10_3389_fneur_2023_1286122
crossref_primary_10_1186_s13102_023_00790_5
crossref_primary_10_5694_mja2_52577
crossref_primary_10_3390_life13071501
crossref_primary_10_3389_fneur_2023_1126215
crossref_primary_10_2147_DNND_S441738
crossref_primary_10_1016_j_msard_2025_106672
crossref_primary_10_1016_j_msard_2022_104088
crossref_primary_10_1016_j_msard_2024_105854
crossref_primary_10_1016_j_msard_2025_106448
crossref_primary_10_1080_09593985_2024_2341993
crossref_primary_10_1016_j_apmr_2022_12_194
crossref_primary_10_3390_sclerosis3020013
crossref_primary_10_3390_sclerosis3020012
crossref_primary_10_5937_medi0_56932
crossref_primary_10_3390_jcm13010214
crossref_primary_10_1007_s00739_025_01073_z
crossref_primary_10_3390_healthcare12060674
crossref_primary_10_1016_j_autrev_2023_103358
crossref_primary_10_1016_j_msard_2022_104198
crossref_primary_10_1016_j_msard_2025_106456
crossref_primary_10_7224_1537_2073_2020_128
crossref_primary_10_1016_j_msard_2024_105529
crossref_primary_10_1016_j_msard_2024_106170
crossref_primary_10_1371_journal_pdig_0000171
crossref_primary_10_1212_WNL_0000000000210226
crossref_primary_10_1007_s10072_024_07416_9
crossref_primary_10_3390_jcm11123505
crossref_primary_10_1007_s12529_024_10265_7
crossref_primary_10_1016_j_jsams_2023_10_009
crossref_primary_10_1016_j_msard_2021_103471
crossref_primary_10_3389_fresc_2022_989658
crossref_primary_10_1038_s41598_021_86593_5
crossref_primary_10_1016_j_mhpa_2023_100541
crossref_primary_10_1016_j_msard_2021_103111
crossref_primary_10_1111_jep_70146
crossref_primary_10_7224_1537_2073_2024_006
crossref_primary_10_1093_ptj_pzaf046
crossref_primary_10_1007_s00415_022_11268_8
crossref_primary_10_36290_neu_2023_076
crossref_primary_10_3390_ijerph182413245
ContentType Journal Article
DBID NPM
7X8
DOI 10.1177/1352458520915629
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0970
ExternalDocumentID 32323606
Genre Journal Article
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
01A
0R~
123
18M
1~K
29M
31R
31S
31U
31X
31Y
31Z
36B
39C
3V.
4.4
53G
54M
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADTT
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AAMGE
AANSI
AAPEO
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWC
ABAWP
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHFT
ABHKI
ABHQH
ABJIS
ABJNI
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSBE
ACSIQ
ACTQU
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZYD
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEUIJ
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFQAA
AFUIA
AFVCE
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AGWNL
AHDMH
AHHFK
AHMBA
AIGRN
AIOMO
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EBS
EJD
EMOBN
ESX
F5P
FD6
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
M4V
N9A
NPM
O9-
P.B
P2P
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
UKHRP
XJT
ZONMY
ZPPRI
ZRKOI
ZSSAH
7X8
AAPII
ABIDT
ABJZC
ADDLC
ADEBD
AJGYC
AJHME
AJVBE
SASJQ
ID FETCH-LOGICAL-c462t-2a7e870f6b6bd515dbdc94fc1de99746c08ff2ac9522a824eaadbc2233cbec5f2
IEDL.DBID 7X8
ISICitedReferencesCount 218
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000531542600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1477-0970
IngestDate Sat Sep 27 21:07:51 EDT 2025
Wed Feb 19 02:30:33 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Multiple sclerosis
disability
wellness
exercise
lifestyle physical activity
recommendations
physical activity
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-2a7e870f6b6bd515dbdc94fc1de99746c08ff2ac9522a824eaadbc2233cbec5f2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4132-2789
0000-0002-5894-2290
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7575303
PMID 32323606
PQID 2394259266
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2394259266
pubmed_primary_32323606
PublicationCentury 2000
PublicationDate 2020-10-01
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Multiple sclerosis
PublicationTitleAlternate Mult Scler
PublicationYear 2020
SSID ssj0007735
Score 2.6648126
Snippet To provide clinicians who treat multiple sclerosis (MS) patients with evidence-based or expert opinion-based recommendations for promoting exercise and...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1459
Title Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course
URI https://www.ncbi.nlm.nih.gov/pubmed/32323606
https://www.proquest.com/docview/2394259266
Volume 26
WOSCitedRecordID wos000531542600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LS8NAEMcHtSJefD_qixG8hiabbTY5iUiLl5YeFHorm31AoU2qaYV-e2eTLb2J4CXkEjZkZnd-szPZP8ATF3mSO3JLreQBF3FEcy4NA8273HYTG4pc1mITYjhMx-Ns5DfcKt9WuVkT64Val8rtkXechDehOsWT58Vn4FSjXHXVS2jsQismlHFeLcbb08KFqAU2Iy5EEGYi3JYpOxGBBydUZhQvCQF-Acw60PSP__uKJ3DkERNfGp84hR1TnMHBwBfRz2Hd8zJLKAuNs6mlEdYzgwtvMnT_OjhJCXTZ8nxuvO5ShQS42LSco9u_xU03IlY0EIXbaYVe96dcLenWoK__oCpds8gFfPR7769vgVdgCBRP2DJgUhia0DYhg2oiH51rlXGrIm0ySkQSFabWMqkyojiZMm6k1Lki4ogV-UbXskvYK8rCXAOSF3BLuCBForlmXEob5hHLBWU0ZJqsDY-bjzohD3dlC1mYclVNtp-1DVeNZSaL5iiOSUxAGFMOdvOHp2_hkLlkue7Eu4OWpflt7mFffS-n1ddD7Tp0HY4GPxKz0NU
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exercise+and+lifestyle+physical+activity+recommendations+for+people+with+multiple+sclerosis+throughout+the+disease+course&rft.jtitle=Multiple+sclerosis&rft.au=Kalb%2C+Rosalind&rft.au=Brown%2C+Theodore+R&rft.au=Coote%2C+Susan&rft.au=Costello%2C+Kathleen&rft.date=2020-10-01&rft.eissn=1477-0970&rft.volume=26&rft.issue=12&rft.spage=1459&rft_id=info:doi/10.1177%2F1352458520915629&rft_id=info%3Apmid%2F32323606&rft_id=info%3Apmid%2F32323606&rft.externalDocID=32323606
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0970&client=summon